1-6 of 6
Jörg Bittenbring
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of FLT3 Inhibitor Maintenance Therapy on Post-Transplant Outcomes in FLT3-Mutated AML Patients: A Real World Analysis from the German Registry for Hematopoietic Stem Cell Transplantation and Cell Therapy (DRST)

Radwan Massoud, Sarah Flossdorf, Franziska Hanke, Thomas Schroeder, Wolfgang Andreas Bethge, Robert Zeiser, Caroline Pabst, Gerald Wulf, Elisa Sala, Inken Hilgendorf, Christof Scheid, Matthias Edinger, Friedrich Stölzel, Igor Wolfgang Blau, Matthias Stelljes, Guido Kobbe, Uwe Platzbecker, Jörg Bittenbring, Matthias Eder, Katharina Fleischhauer, Andreas Burchert, Christoph Schmid, Nicolaus Kroeger
Journal: Blood
Blood (2024) 144 (Supplement 1): 3560.
https://doi.org/10.1182/blood-2024-210920
Published: 2024
Journal Articles

A Randomized, Open-Label, Phase 3 Study of Acalabrutinib in Combination with Rituximab and Reduced Dose CHOP (R-miniCHOP) in Older Adults with Untreated Diffuse Large B-Cell Lymphoma (ARCHED / GLA 2022-1)

Konstantinos Christofyllakis, Viola Poeschel, Bettina Altmann, Stephanie Maurer, Vadim Lesan, Jörg Bittenbring, Igor Age Kos, Dominic Kaddu-Mulindwa, Zanir Abdi, Octavian Fleser, Sarah Altmeyer, Nina Rosa Neuendorff, Maike Nickelsen, Gerhard Held, Martin Dreyling, Florian Zettl, Christian Buske, Georg Lenz, Bertram Glass, Bjoern Chapuy, Norbert Schmitz, Theodoros Vassilakopoulos, German Ott, Reiner Siebert, Andreas Viardot, Florian Scherer, Roland Schmitz, Andreas Rosenwald, Dirk Hellwig, Markus Loeffler, Stephan Stilgenbauer, Lorenz Thurner, Moritz Bewarder, Marita Ziepert
Journal: Blood
Blood (2023) 142 (Supplement 1): 6248.
https://doi.org/10.1182/blood-2023-179200
Published: 2023
Journal Articles

MRD-Guided Zanubrutinib, Venetoclax and Obinutuzumab after an Optional Debulking with Bendamustine in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: Primary Endpoint Analysis of the Phase 2 CLL2-Bzag Study

Moritz Furstenau, Adam Giza, Christof Schneider, Eugen Tausch, Sandra Robrecht, Matthias Ritgen, Jörg Bittenbring, Holger F. Hebart, Björn Schöttker, Anna Lena Illert, Ullrich Graeven, Andrea Stoltefuss, Bernhard Heinrich, Robert Eckert, Anna-Maria Fink, Janina Stumpf, Florian Simon, Kirsten Fischer, Othman Al-Sawaf, Petra Langerbeins, Fanni Kleinert, Jonathan Weiss, Karl-Anton Kreuzer, Anke Schilhabel, Monika Brüggemann, Barbara F. Eichhorst, Stephan Stilgenbauer, Michael Hallek, Paula Cramer
Journal: Blood
Blood (2023) 142 (Supplement 1): 1897.
https://doi.org/10.1182/blood-2023-173707
Published: 2023
Journal Articles

Hematopoietic Stem Cell Transplantation for DLBCL: 55,000 Cases from EBMT As a Comparator for CAR T-Cells

Philipp Berning, Ariane Boumendil, Anthony H. Goldstone, Anna Maria Sureda Balari, Peter Dreger, Silvia Montoto, Maud Ngoya, Hervé Finel, Patrice Chevallier, Didier Blaise, Tim Struessmann, Ben Carpenter, Edouard Forcade, Cristina Castilla-Llorente, Marek Trněný, Herve Ghesquieres, Capria Saveria, Catherine Thieblemont, Igor Wolfgang Blau, Ellen Meijer, Annoek E.C. Broers, Anne Huynh, Denis Caillot, Wolf Roesler, Stéphanie Nguyen Quoc, Jörg Bittenbring, Arnon Nagler, Bertram Glass, Norbert Schmitz
Journal: Blood
Blood (2023) 142 (Supplement 1): 441.
https://doi.org/10.1182/blood-2023-184788
Published: 2023
Journal Articles

Blocking the CD47-Sirpa Axis Enhances Tafasitamab-Mediated Phagocytosis

Alexander Biedermann, Doris Mangelberger-Eberl, Dimitrios Mougiakakos, Maike Büttner-Herold, Cindy Flamann, Christian Kellner, Sarah Altmeyer, Jörg Bittenbring, Christian Augsberger, Maria Patra-Kneuer, Karin Landgraf, Kristina Ilieva-Babinsky, Stefan Haskamp, Fabian Beier, Simon Voelkl, Christian Pallasch, Benedikt Jacobs, Stefan Steidl, Christina Heitmüller, Andreas Mackensen, Heiko Bruns
Journal: Blood
Blood (2022) 140 (Supplement 1): 9292–9293.
https://doi.org/10.1182/blood-2022-159955
Published: 2022
Journal Articles

Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial

Clinical Trials & Observations
Isabelle Krämer, Stephan Stilgenbauer, Sascha Dietrich, Sebastian Böttcher, Matthias Zeis, Michael Stadler, Jörg Bittenbring, Lutz Uharek, Christof Scheid, Ute Hegenbart, Anthony Ho, Michael Hallek, Michael Kneba, Norbert Schmitz, Hartmut Döhner, Peter Dreger
Journal: Blood
Blood (2017) 130 (12): 1477–1480.
https://doi.org/10.1182/blood-2017-04-775841
Published: 2017
Includes: Supplemental data